Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release

European Journal of Neuroscience

Volumn 20, Issue 1, 2004, Pages 229-239

  Merali, Z ^a   Khan, S ^a   Michaud, D S ^a   Shippy, S A ^a,b   Anisman, H ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c CARLETON UNIVERSITY   (Canada)

Author keywords

Amygdala; Anxiety; Corticotropin releasing factor (CRF); Gastrin releasing peptide; Glutamate; Stress

Indexed keywords

ANXIOLYTIC AGENT; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; DIAZEPAM; GLUTAMIC ACID; SAUVAGINE;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENVIRONMENTAL FACTOR; FEEDING BEHAVIOR; FOOD INTAKE; HORMONAL REGULATION; HORMONE RELEASE; IMMOBILIZATION; MALE; NEUROCHEMISTRY; NONHUMAN; PALATABILITY; PRIORITY JOURNAL; RAT; SHOCK; STIMULUS RESPONSE; STRESS;

AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BOMBESIN; BRAIN CHEMISTRY; CORTICOTROPIN-RELEASING HORMONE; DIAZEPAM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; ELECTROSHOCK; ENVIRONMENT; GLUTAMIC ACID; HORMONE ANTAGONISTS; MALE; MICRODIALYSIS; PEPTIDE FRAGMENTS; PYRIMIDINES; PYRROLES; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 3142727645     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03468.x     Document Type: Article

References (76)

1. Anderson, A.K. & Phelps, E.A. (2001) Lesions of the human amygdala impair enhanced perception of emotionally salient events. Nature, 411, 305-309.
2. Baklavadzhyan, O.G., Pogosyan, N.L., Arshakyan, A.V., Darbinyan, A.G., Khachatryan, A.V. & Kikogosyan, T.G. (2000) Studies of the role of the central nucleus of the amygdala in controlling cardiovascular functions. Neurosci. Behav. Physiol., 30, 231-236.
3. Bakshi, V.P., Smith-Roe, S., Newman, S.M., Grigoriadis, D.E. & Kalin, N.H. (2002) Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala. J. Neurosci., 22, 2926-2935.
4. Baldwin, H.A., Hitchcott, P.K. & File, S.E. (1989) Evidence that the increased anxiety detected in the elevated plus-maze during chlordiazepine withdrawal is not due to enhanced noradrenergic activity. Pharmacol. Biochem. Behav., 34, 931-933.
5. Bale. T.L., Contarino, A.B., Smith, G.W., Chan, R., Gold, L.H., Sawchenko, P.E., Koob, G.F., Vale, W.W. & Lee, K.F. (2000) Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nature General, 24, 410-414.
6. Bale, T.L., Picetti, R., Contarino, A., Koob, G.F., Vale, W.W. & Lee, K.F. (2002) Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J. Neurosci., 22, 193-199.
7. Bale, T.L. & Vale, W.W. (2003) Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses. J. Neurosci., 23, 5295-5301.
8. Berridge, K.C. (2003) Pleasures of the brain. Brain Cogn., 52, 106-128.
9. Biro, E., Sarnyai, Z., Penke, B., Szabo, G. & Telegdy, G. (1993) Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats. Neuroendocrinology, 57, 340-345.
10. Blanchard, R.J., Griebel, G., Henrie, J.A. & Blanchard, D.C. (1997) Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries. Neurosci. Biobehav. Rev., 21, 783-789.
11. Bodnoff, S.R., Suranyi-Cadotte, B.E., Quirion, R. & Meaney, M.J. (1989a) A comparison of the effects of diazepam versus several typical and atypical antidepressant drugs in an animal model of anxiety. Psychopharmacol. (Berl.), 97, 277-279.
12. Bodnoff, S.R., Suranyi-Cadotte, B., Quirion, R. & Meaney, M.J. (1989b) Role of the central benzodiazepine receptor system in behavioral habituation to novelty. Behav. Neurosci., 103, 209-212.
13. Britton, D.R. & Britton, K.T. (1981) A sensitive open field measure of anxiolytic drug activity. Pharmacol. Biochem. Behav., 15, 577-582.
14. Britton, D.R., Hoffman, D.K., Lederis, K. & Rivier, J. (1984) A comparison of the behavioral effects of CRF, sauvagine and urotensin 1. Brain Res., 304, 201-205.
15. Britton, D.R. & Indyk, E. (1989) Effects of ganglionic blocking agents on behavioral responses to centrally administered CRF. Brain Res., 478, 205-210.
16. Britton, K.T., Morgan, J., Rivier, J., Vale, W. & Koob, G.F. (1985) Chlordiazepoxide attenuates response suppression induced by corticotropin- releasing factor in the conflict test. Psychopharmacology, 86, 170-174.
17. Bruijnzeel, A.W., Stam, R. & Wiegant, V.M. (2001) Effect of a benzodiazepine receptor agonist and corticotropin-releasing hormone receptor antagonists on long-term foot-shock-induced increase in defensive withdrawal behavior. Psychopharmacology (Berl.), 158, 132-139.
18. Cook, C.J. (2001) Measuring of extracellular cortisol and corticotropin-releasing hormone in the amygdala using immunosensor coupled microdialysis. J. Neurosci. Meth., 110, 95-101.
19. Coste, S.C., Kesterson, R.A., Heldwein, K.A., Stevens, S.L., Heard, A.D., Hollis, J.H., Murray, S.E., Hill, J.K., Pantely, G.A., Hohimer, A.R., Hatton, D.C., Phillips, T.J., Finn, D.A., Low, M.J., Rittenberg, M.B., Stenzel, P. & Stenzel-Poore, M.P. (2000) Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nature Genet., 24, 403-409.
20. Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J.P., Belzung, C., Fritschy, J.M., Luscher, B. & Mohler, H. (1999) Decreased GABA(A)-receptor clustering results in enhanced anxiety and a bias for threat cues. Nature Neurosci., 2, 833-839.
21. Davis, M. (1992) The role of the amygdala in fear and anxiety. Ann. Rev. Neurosci., 15, 353-375.
22. Davis, M. (1998) Are different parts of the extended amygdala involved in fear versus anxiety? Biol. Psychiatry, 44, 1239-1247.
23. Davis, M., Rainnie, D. & Cassell, M. (1994) Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci., 17, 208-214.
24. Deak, T., Nguyen, K.T., Ehrlich, A.L., Watkins, L.R., Spencer, R.L., Maier, S.F., Licinio, J., Wong, M.L., Chrousos, G.P., Webster, E. & Gold, P.W. (1999) The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology, 140, 79-86.
25. Deutch, A.Y., Bourdelais, A.J. & Zahm, D.S. (1993) The nucleus accumbens core and shell: accumbal compartments and their functional attributes. In: Kalivas, P.W. & Barnes, C.D. (Eds), Limbic Motor Circuits and Neuropsychiatry. Boca Raton, FL, pp. 45-88.
26. Dunn, A.J. & Berridge, C.W. (1990) Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Rev., 15, 71-100.
27. Eghbal-Ahmadi, M., Avishai-Eliner, S., Hatalski, C.G. & Baram, T.Z. (1999) Differential regulation of the expression of corticotropin-releasing factor receptor type 2 (CRF2) in hypothalamus and amygdala of the immature rat by sensory input and food intake. J. Neurosci., 19, 3982-3991.
28. Gabr, R.W., Birkle, D.L. & Azzaro, A.J. (1995) Stimulation of the amygdala by glutamate facilitates corticotropin-releasing factor release from the median eminence and activation of the hypothalamic-pituitary-adrenal axis in stressed rats. Neuroendocrinology, 62, 333-339.
29. Gaffan, E.A., Gaffan, D. & Harrison, S. (1988) Disconnection of the amygdala from visual association cortex impairs visual reward association in monkeys. J. Neurosci., 8, 3144-3150.
30. Griebel, G., Perrault, G. & Sanger, D.J. (1998) Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology (Berl.), 138, 55-66.
31. Habib, K.E., Weld, K.P., Rice, K.C., Pushkas, J., Champoux, M., Listwak, S., Webster, E.L., Atkinson, A.J., Schulkin, J., Contoreggi, C., Chrousos, G.P., McCann, S.M., Suomi, S.J., Higley, J.D. & Gold, P.W. (2000) Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates (vol. 97, pp. 6079, 2000). Proc. Natl Acad. Sci. USA. 97, 8745.
32. Heinrichs, S.C. & Joppa, M. (2001) Dissociation of arousal-like from anxiogenic-like actions of brain corticotropin-releasing factor receptor ligands in rats. Behav. Brain Res., 122, 43-50.
33. Heinrichs, S.C., Menzaghi, F., Pich, E.M., Baldwin, H.A., Rassnick, S., Britton, K.T. & Koob, G.F. (1994) Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity. Neuropsychopharmacology, 11, 179-186.
34. Herman, J.P. & Cullinan, W.E. (1997) Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci., 20, 78-84.
35. Hikichi, T., Akiyoshi, J., Yamamoto, Y., Tsutsumi, T., Isogawa, K. & Nagayama, H. (2000) Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526. Pharmacopsychiatry, 33, 189-193.
36. Jasnow, A.M., Banks, M.C., Owens, E.G. & Huhman, K.L. (1999) Differential effects of two corticotropin-releasing factor antagonists on conditioned defeat in male Syrian hamsters (Mesocricetus auratus). Brain Res., 846, 122-128.
37. Jones, B. & Mishkin, M. (1972) Limbic lesions and the problem of stimulus-reinforcement associations. Exp. Neurol., 36, 362-377.
38. Kalin, N.H., Takahashi, L.K. & Chen, F.-T.A. (1994) Restraint stress increases corticotropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus. Brain Res., 656, 182-186.
39. Keck, M.E., Welt, T., Wigger, A., Renner, U., Engelmann, M., Holsboer, F. & Landgraf, R. (2001) The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats. Eur. J. Neurosci., 13, 373-380.
40. Kent, P., Anisman, H. & Merali, Z. (1997) Are bombesin-like peptides involved in the mediation of the stress response? Life Sci., 62, 103-114.
41. Khan, S., Michaud, D., Anisman, H. & Merali, Z. (1999) Diazepam reverses novel environment-induced feeding suppression without blocking amygdaloid CRH release. Soc. Neurosci. Abstr., 25, 1126.
42. de Kloet, R.E. (2003) Hormones, brain and stress. Endocrinol. Regul., 37, 51-68.
43. Koob, G.F. & Heinrichs, S.C. (1999) A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res., 848, 141-152.
44. Kusnecov, A.W., Liang, R.M. & Shurin, G. (1999) T-lymphocyte activation increases hypothalamic and amygdaloid expression of CRH mRNA and emotional reactivity to novelty. J. Neurosci., 19, 4533-4543.
45. LeDoux, J.E. (2000) Emotion circuits in the brain. Ann. Rev. Neurosci. 23 155-184.
46. Makino, S., Takemura, T., Asaba, K., Nishiyama, M., Takao, T. & Hashimoto, K. (1997) Differential regulation of type-1 and type-2alpha corticotropin-releasing hormone receptor mRNA in the hypothalamic paraventricular nucleus of the rat. Brain Res. Mol. Brain Res., 47, 170-176.
47. McKernan, R.M., Wafford, K., Quirk, K., Hadingham, K.L., Harley, E.A., Ragan, C.I. & Whiting, P.J. (1995) The pharmacology of the benzodiazepine site of the GABA-A receptor is dependent on the type of gamma-subunit present. J. Recept. Signal. Transduct. Res., 15, 173-183.
48. Merali, Z., Levac, C. & Anisman, H. (2003) Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice. Biol. Psychiatry, 54, 552-565.
49. Merali, Z., McIntosh, J. & Anisman, H. (2004) Anticipatory cues differentially provoke in vivo peptidergic and monoaminergic release at the medial prefrontal cortex. Neuropsychopharmacology, in press.
50. Merali, Z., McIntosh, J., Kent, P., Michaud, D. & Anisman, H. (1998) Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala. J. Neurosci., 18, 4758-4766.
51. Muller, M.B. (2002) Essential role of limbic corticotropin-releasing hormone receptor 1 in neuroendocrine adaptation to stress and anxiety-related behavior. Am. J. Medical General, 114, 884.
52. Muller-Gass, A., Porath, A., Anisman, H. & Merali, Z. (2000) Novelty-induced delay in snack approach: a robust and rapid naturalistic model for anxiety assessment. Soc. Neurosci. Abstr., 30, 659.2.
53. Nakagawa, T., Katsuya, A., Tanimoto, S., Yamamoto, J., Yamauchi, Y., Minami, M. & Satoh, M. (2003) Differential patterns of c-fos mRNA expression in the amygdaloid nuclei induced by chemical somatic and visceral noxious stimuli in rats. Neurosci. Lett., 344, 197-200.
54. Okuyama, S., Chaki, S., Kawashima. N., Suzuki, Y., Ogawa, S.I., Nakazato, A., Kumagai, T., Okubo, T. & Tomisawa, K. (1999) Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin- releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001. J. Pharmacol. Exp. Ther., 289, 926-935.
55. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
56. Pelleymounter, M.A., Joppa, M., Ling, N. & Foster, A.C. (2002) Pharmacological evidence supporting a role for central corticotropin-releasing factor2 receptors in behavioral, but not endocrine, response to environmental stress. J. Pharmacol. Exp. Ther., 302, 145-152.
57. Pich, E.M., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G.F. & Weiss, F. (1995) Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci., 15, 5439-5447.
58. Rex, A., Stephans, S.E. & Fink, H. (1996) 'Anxiolytic' action of diazepam and abecarnil in a modified open field test. Pharmacol. Biochem. Behav., 53, 1005-1011.
59. Richard, D., Rivest, R., Naimi, N., Timofeeva, E. & Rivest, S. (1996) Expression of corticotropin-releasing factor and its receptors in the brain of lean and obese Zucker rats. Endocrinology, 137, 4786-4795.
60. Richter, R.M., Pich, E.M., Koob, G.F. & Weiss, F. (1995) Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neurosci. Lett., 187, 169-172.
61. Rodŕiguez de Fonseca, F., Carrera, M.R.A., Navarro, M., Koob, G.F. & Weiss, F. (1997) Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science, 276, 2050-2054.
62. Rolls, E.T. (2000) The orbitofrontal cortex and reward. Cereb. Cortex, 10, 284-294.
63. Sajdyk, T.J., Katner, J.S. & Shekhar, A. (1997) Monoamines in the dorsomedial hypothalamus of rats following exposure to different tests of 'anxiety'. Prog. Neuro-Psychopharmacol. Biol. Psychiat., 21, 193-209.
64. Sapolsky, R.M., Romero, L.M. & Munck, A.U. (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrinol. Rev., 21, 55-89.
65. Smith, G.W., Aubry, J.M., Dellu, F., Contarino, A., Bilezikjian, L.M., Gold, L.H., Chen, R., Marchuk, Y., Hauser, C., Bentley, C.A., Sawchenko, P.E., Koob, G.F., Vale, W. & Lee, K.F. (1998) Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron, 20, 1093-1102.
66. Spina, M.G., Basso, A.M., Zorrilla, E.P., Heyser, C.J., Rivier, J., Vale, W., Merlo-Pich, E. & Koob, G.F. (2000) Behavioral effects of central administration of the novel CRF antagonist astressin in rats. Neuropsychopharmacology, 22, 230-239.
67. Spina, M.G., Merlo-Pich, E., Akwa, Y., Balducci, C., Basso, A., Zorrilla, E.P., Britton, K.T., Rivier, J., Vale, W.W. & Koob, G.F. (2002) Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat. Psychopharmacology, 160, 113-121.
68. Steckler, T. & Holsboer, M. (1999) Corticotropin-releasing hormone receptor subtypes and emotion. Biolog. Psychiatry, 46, 1480-1508.
69. Stout, J.C. & Weiss, J.M. (1994) An animal model for measuring behavioral responses to anxiogenic and anxiolytic manipulations. Pharmacol. Biochem. Behav., 47, 459-465.
70. Sutton, R.E., Koob, G.F., Le Moal, M., Rivier, J. & Vale, W. (1982) Corticotropin releasing factor produces behavioral activation in rats. Nature, 297, 331-333.
71. Swiergiel, A.H., Takahashi, L.K. & Kalin, N.H. (1993) Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat. Brain Res., 623, 229-234.
72. Takahashi, L.K. (2001) Role of CRF (1) and CRF (2) receptors in fear and anxiety. Neurosci. Biobehav. Rev., 25, 627-636.
73. Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J.M., Stalla, G.K., Blanquet, V., Steckler, T., Holsboer, F. & Wurst, W. (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genet., 19, 162-166.
74. Walker, D.L. & Davis, M. (1997) Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J. Neurosci., 17, 9375-9383.
75. Walker, D.L. & Davis, M. (2002) The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacol. Biochem. Behav., 71, 379-392.
76. Weninger, S.C., Dunn, A.J., Muglia, L.J., Dikkes, P., Miczek, K.A., Swiergiel, A.H., Berridge, C.W. & Majzoub, J.A. (1999) Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc. Natl Acad. Sci. USA, 96, 8283-8288.